Haleon highlighted consistent market share gains in China as it reported third-quarter results.
A double-digit gain in China helped Haleon deliver mid-single-digit sales growth in the third quarter.
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
Haleon now holds 88% of its China OTC joint venture after acquiring a larger stake in the business from its local partners.
APAC health agencies such as WHO and Thailand's FDA are on board with the self-care agenda, and see it as crucial to achieving universal health coverage.
Haleon highlighted consistent market share gains in China as it reported third-quarter results.
Joint venture business which markets Haleon's OTC drug brands in China will soon be 88% owned by the UK-based firm.
HHS Secretary Kennedy commends food companies for cooperating, but also says, “We have them on the run now and we are going to win this battle. And four years from now, we're going to have most of these products off the market.”
Concern is unavoidable for most marketers of OTC drugs and dietary supplements in the US. As Canaccord Genuity analysts said in a 15 April research note, “uncertainty remains about how the tariff situation will play out.”
HHS Secretary Robet F. Kennedy Jr. and FDA Commissioner Marty Makary to announce planned changes as “a major step forward” as part of Kennedy’s “Make America Healthy Again” campaign President Trump has adopted for his administration.
